One major limitation in this study was the lack of proper standardised immunohistochemical techniques for the assessment of PDL1. The difference in the staining methodologies as well as the usage of different antibodies for staining the tumor cells in various studies also prevented the assessment of their performance. This evidence concerns the gene CD274 and neoplasm.